01 / SCALE

One global name. Many different lives inside it.

The numbers describe immense burden and a deep treatment gap. They do not tell us who the person is, which symptom pattern they carry, what caused it or which treatment will fit.

332M

people living with depression worldwide

WHO modelled estimate, published in 2025

5.7%

of adults worldwide

A population estimate, not a prediction about one person

9.1%

of people with major depressive disorder received minimally adequate treatment in 2021

Coverage was about 27% in high-income settings and about 2% in sub-Saharan Africa

1,030

distinct symptom profiles in 3,703 STAR*D participants

The same diagnosis can contain very different lived and biological problems

Diagnosis organizes information and enables care; it does not reveal one hidden essence. Two people can meet the same criteria with nearly opposite patterns of sleep, appetite, movement, anxiety, pleasure and risk.

02 / THE NEW SYNTHESIS

The Reciprocal Reachability Field

The model asks two separate questions: what can the person reach from the present state—action, relationship, care, work or a credible tomorrow; and what from life can reach the person strongly enough to register—care, safety, pleasure, rest or evidence that something changed. It is a research and formulation scaffold, not a score, diagnosis or treatment algorithm.

01

Body

Can the body mobilize?

Sleep, pain, appetite, inflammation, movement, hormones and medication can alter the energetic price of every next step.

02

Mind

What can attention and imagination hold?

Rumination, self-criticism, threat prediction and cognitive slowing can make one interpretation feel final while alternatives disappear.

03

World

What does the environment permit?

Housing, work, money, discrimination, transport, violence and access to care are not background variables. They change which actions are truly available.

04

Relationships

Can care travel in both directions?

Depression can make asking, answering and receiving care difficult. Support helps most when it preserves the autonomy and limits of everyone involved.

05

Future

Can tomorrow exert force now?

A future may be intellectually imaginable yet too distant, costly or implausible to shape present action. Recovery can begin with a credible hour, not a five-year vision.

OUTGOINGperson → life

initiation, effort, help-seeking, tolerating uncertainty

INCOMINGlife → person

registering care, reward, safety, correction and restoration

03 / BEYOND ‘NO PLEASURE’

Anhedonia separates into six different clinical questions.

A person can enjoy an event once it happens but fail to anticipate it; value a goal but be unable to pay the effort cost; act without receiving a reward signal; or have a better outcome that fails to revise the next prediction. ‘Low motivation’ erases these differences.

01

Anticipation

Can a possible good be felt before it arrives?

02

Effort

What does the route cost from this body-state?

03

Action

Can value become a first movement?

04

Experience

Does reward register when it arrives?

05

Learning

Can a better outcome revise the prediction?

06

Return

After a bad interval, is there more than one way back?

The first sign of recovery may be one more available action before happiness arrives.

04 / BRODMANN 25

Area 25 teaches discovery and scientific self-correction.

The subgenual cingulate, often discussed as Brodmann area 25, sits near pathways involved in body state, valuation, emotion regulation and action. In current deep-brain-stimulation research, the candidate target is increasingly treated not as one identical coordinate but as a possible convergence of pathways for a particular candidate. That remains a specialist research hypothesis—not settled routine care.

1997–1999

A network, not a mood centre

Helen Mayberg and colleagues used converging imaging findings to describe reciprocal changes across subgenual cingulate and cortical-limbic systems. Area 25 became a network junction hypothesis—not a depression button.

2005

Open-label deep brain stimulation

An influential small study reported sustained improvement in some people with otherwise highly treatment-resistant depression. It established scientific possibility, not settled efficacy.

2017

BROADEN: the necessary negative result

A larger randomized sham-controlled trial was stopped for futility after the planned analysis did not show a significant advantage over sham. The result corrected the story rather than ending the field.

2018–2025

From coordinates to pathways

Tractography, longitudinal physiology and individualized targeting increasingly ask which white-matter pathways converge for a particular candidate. Encouraging pooled long-term outcomes remain specialist evidence; they do not erase BROADEN or establish routine efficacy.

Now

A research platform with surgical burden

Subcallosal-cingulate DBS remains experimental for depression. Incisionless is not the same as minimally burdensome—and implanted stimulation is neither. Surgery, hardware, programming, long follow-up and rescue capacity are part of the intervention.

05 / EVIDENCE LADDER

Choose a sufficient lever—and count the whole infrastructure.

Regulatory status, effect size, novelty, anatomical invasiveness and lived burden are different axes. Treatment is chosen through diagnosis, severity, urgency, prior response, preference, comorbidity, access and what can continue afterward.

01

Usable in ordinary clinical pathways

Established

A careful diagnosis and safety plan; structured psychotherapies such as behavioral activation, cognitive behavioral therapy (CBT), interpersonal and problem-solving therapy; antidepressants through shared decisions; collaborative care; adapted exercise; and, for selected states, electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) or intermittent theta-burst stimulation (iTBS).

02

Evidence or authorization is not enough by itself

Conditional and infrastructure-bound

Regulated esketamine, specialist IV ketamine, accelerated intermittent theta-burst stimulation (iTBS), supervised prescription transcranial direct-current stimulation (tDCS), correctly timed bright-light treatment and selected implanted vagus-nerve stimulation (VNS) pathways require eligibility checks, monitoring, transport or device support, continuity and a plan for relapse or adverse effects.

03

A research question, not a consumer option

Experimental

Subcallosal-cingulate or closed-loop DBS, magnetic seizure therapy, nonablative focused ultrasound, temporal-interference stimulation, psychedelic-assisted approaches and biomarker-led matching belong in regulated studies or highly governed specialist pathways—not in self-directed care.

04

The boundary is part of the evidence

Do not operationalize

Do not treat compounded take-home ketamine as equivalent to a monitored protocol, build DIY brain stimulation, read a biomarker as destiny, use supplements as a rescue treatment, or stop psychiatric medication abruptly. Novelty does not create the missing safety system.

KETAMINE / ESKETAMINE

Speed does not replace a care system.

Ketamine and esketamine can produce a rapid antidepressant signal for some people, but context is part of the intervention: diagnosis and eligibility, blood pressure and medical status, dissociation, misuse risk, observation, transport, continuation care and a plan if benefit fades. Take-home compounded products are not equivalent to the protocols studied. This reservation is not fear of innovation; it recognizes that infrastructure is part of treatment.

06 / BODY · RHYTHM · WORLD

Treatment does not happen only in a room or at a receptor.

MOVEMENT & SPORT

Match the dose to capacity; never make it a character test.

Meta-analyses support exercise as a possible depression treatment, with a moderate short-term effect compared with no treatment or control. Long-term evidence is less certain, and attrition, severity and support matter. Accompanied walking, resistance training, aerobic activity, yoga or brief movement can be different entry points; severe depression, pain and medical illness require adaptation.

SLEEP, LIGHT & RHYTHM

Give tomorrow a biological shape.

CBT for insomnia, a stable wake time and correctly timed light can be part of care. ‘Sleep hygiene’ is not an adequate answer to sleep apnoea, trauma nightmares, manic sleep loss, withdrawal, medication effects or unsafe housing. Bright light needs particular caution when bipolarity is possible.

FOOD & SUPPLEMENTS

A possible adjunct, never a rescue treatment.

Some dietary interventions show a promising signal, but studies are small and socioeconomic context matters. Omega-3 findings are mixed and certainty is limited; creatine has interesting early evidence but not a basis for universal recommendation. Folate, vitamin D, B12, iron or other supplements should follow dietary context, clinically indicated deficiency assessment, interactions, kidney disease and other medical factors—with professional review.

EASTERN WISDOM

Presence without spiritual bypass.

Mindfulness, compassion, yoga and traditions of non-attachment can help a person meet a thought as an event rather than a verdict. They do not prove suffering is illusion, repair poverty or violence, or replace treatment for dangerous depression. Practice can also overwhelm, dissociate or harm some people; fit, choice and permission to stop are essential.

07 / SUPPORT SYSTEMS

Recovery needs an ecosystem, not one heroic person.

01

For the person

Borrow structure when internal force is low: a booked appointment, transport, a simple meal, a sleep window, one small task and one observable sign of change. Asking for help is not evidence of failure; it may be the most complex action still reachable.

02

For a loved one

Ask directly about safety when there is reason, offer a concrete action, do not debate despair as if it were merely a faulty argument, and protect your own boundaries, sleep, finances and safety. Love does not require becoming a crisis service or the whole treatment system.

03

For the clinician

Separate observation, diagnosis, mechanism hypothesis and plan; measure function, risk, adverse effects and life rather than only a score; revise when movement is absent; and decide at the outset what happens after benefit, partial benefit or nonresponse.

04

For the system

Availability without continuity is not real access. Care includes language, cost, transport, childcare, booked follow-up, handoffs between services and a rapid route back when deterioration begins. Housing, work and material-security policy are also mental-health policy.

08 / REACH

A five-minute thinking protocol—not a treatment algorithm.

REACH does not replace professional assessment. It helps prevent a common error: demanding action before checking risk, embodiment, cost, relationship and follow-through.

R
Risk and reality
Check immediate safety, bipolarity, psychosis, substances, withdrawal, medical contributors and what the person says is happening.
E
Energy and embodiment
Map sleep, pain, movement, food, medication, hormones, illness and the bodily cost of the next action.
A
Access and action
Find one safe step that is physically executable now; do not demand motivation as the entry fee.
C
Couplings and care
Look for loops among rumination, avoidance, isolation, sleep, work and relationships—and distribute support so no loved one becomes the whole system.
H
Horizon and handoff
Build a credible near future, name who follows up, decide what would trigger escalation and review whether life is actually widening.

The aim is not to feel good immediately; it is to make the next safe step more reachable and ensure someone carries the handoff.

BASE LECTURE · 48

112 sections. 14 parts. One map built to open into deeper lectures.

The complete edition moves from epidemiology and diagnosis through psychology, Brodmann area 25, body-brain systems, computational psychiatry, nonlinear dynamics, psychotherapy, medication, neuromodulation, rapid care, movement, nutrition, Eastern wisdom and the whole recovery ecosystem.

Open the complete web edition

ENEnglish PDF↗עבPDF בעברית↗↳Reading Room↗

09 / SELECTED SOURCES

Sources also show where a claim must stop.

This is a curated entry list, not a complete systematic review. Lecture 48 carries denser research anchors for each of its 112 sections.

When reach collapses.